222 related articles for article (PubMed ID: 30758662)
1. Helminths protect against type 1 diabetes: effects and mechanisms.
Tang CL; Zou JN; Zhang RH; Liu ZM; Mao CL
Parasitol Res; 2019 Apr; 118(4):1087-1094. PubMed ID: 30758662
[TBL] [Abstract][Full Text] [Related]
2. Helminth protection against type-1 diabetes: an insight into immunomodulatory effect of helminth-induced infection.
Mughal MAS; Khan MK; Abbas Z; Abbas RZ; Bajwa HUR; Chatha AK; Imran M; Sindhu ZUD; Abbas A; Zafar A; Nadeem M
Mol Biol Rep; 2021 Sep; 48(9):6581-6588. PubMed ID: 34432219
[TBL] [Abstract][Full Text] [Related]
3. Induced regulatory T cells suppress Tc1 cells through TGF-β signaling to ameliorate STZ-induced type 1 diabetes mellitus.
Zhou L; He X; Cai P; Li T; Peng R; Dang J; Li Y; Li H; Huang F; Shi G; Xie C; Lu Y; Chen Y
Cell Mol Immunol; 2021 Mar; 18(3):698-710. PubMed ID: 33446887
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction.
Bellinghausen I; König B; Böttcher I; Knop J; Saloga J
Clin Exp Allergy; 2006 Dec; 36(12):1546-55. PubMed ID: 17177678
[TBL] [Abstract][Full Text] [Related]
5. TLR2- and Dectin 1-associated innate immune response modulates T-cell response to pancreatic β-cell antigen and prevents type 1 diabetes.
Karumuthil-Melethil S; Sofi MH; Gudi R; Johnson BM; Perez N; Vasu C
Diabetes; 2015 Apr; 64(4):1341-57. PubMed ID: 25377877
[TBL] [Abstract][Full Text] [Related]
6. Roles of cytokines in the pathogenesis and therapy of type 1 diabetes.
Rabinovitch A; Suarez-Pinzon WL
Cell Biochem Biophys; 2007; 48(2-3):159-63. PubMed ID: 17709885
[TBL] [Abstract][Full Text] [Related]
7. Viral infection prevents diabetes by inducing regulatory T cells through NKT cell-plasmacytoid dendritic cell interplay.
Diana J; Brezar V; Beaudoin L; Dalod M; Mellor A; Tafuri A; von Herrath M; Boitard C; Mallone R; Lehuen A
J Exp Med; 2011 Apr; 208(4):729-45. PubMed ID: 21444661
[TBL] [Abstract][Full Text] [Related]
8. Role of regulatory T cells in Schistosoma-mediated protection against type 1 diabetes.
Tang CL; Gao YR; Wang LX; Zhu YW; Pan Q; Zhang RH; Xiong Y
Mol Cell Endocrinol; 2019 Jul; 491():110434. PubMed ID: 31078638
[TBL] [Abstract][Full Text] [Related]
9. Harnessing memory adaptive regulatory T cells to control autoimmunity in type 1 diabetes.
Li CR; Baaten BJ; Bradley LM
J Mol Cell Biol; 2012 Feb; 4(1):38-47. PubMed ID: 22116888
[TBL] [Abstract][Full Text] [Related]
10. Plasmacytoid dendritic cells license regulatory T cells, upon iNKT-cell stimulation, to prevent autoimmune diabetes.
Beaudoin L; Diana J; Ghazarian L; Simoni Y; Boitard C; Lehuen A
Eur J Immunol; 2014 May; 44(5):1454-66. PubMed ID: 24481989
[TBL] [Abstract][Full Text] [Related]
11. Adoptive transfer of immunomodulatory M2 macrophages prevents type 1 diabetes in NOD mice.
Parsa R; Andresen P; Gillett A; Mia S; Zhang XM; Mayans S; Holmberg D; Harris RA
Diabetes; 2012 Nov; 61(11):2881-92. PubMed ID: 22745325
[TBL] [Abstract][Full Text] [Related]
12. On the Role IL-4/IL-13 Heteroreceptor Plays in Regulation of Type 1 Diabetes.
Ukah TK; Cattin-Roy AN; Chen W; Miller MM; Barik S; Zaghouani H
J Immunol; 2017 Aug; 199(3):894-902. PubMed ID: 28646042
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of carbonyl iron against multiple low-dose streptozotocin-induced diabetes in rodents.
Vujicic M; Saksida T; Mostarica Stojkovic M; Djedovic N; Stojanovic I; Stosic-Grujicic S
J Cell Physiol; 2018 Jun; 233(6):4990-5001. PubMed ID: 29215791
[TBL] [Abstract][Full Text] [Related]
14. Helminth infections decrease host susceptibility to immune-mediated diseases.
Weinstock JV; Elliott DE
J Immunol; 2014 Oct; 193(7):3239-47. PubMed ID: 25240019
[TBL] [Abstract][Full Text] [Related]
15. Intestinal helminths regulate lethal acute graft-versus-host disease and preserve the graft-versus-tumor effect in mice.
Li Y; Chen HL; Bannick N; Henry M; Holm AN; Metwali A; Urban JF; Rothman PB; Weiner GJ; Blazar BR; Elliott DE; Ince MN
J Immunol; 2015 Feb; 194(3):1011-20. PubMed ID: 25527786
[TBL] [Abstract][Full Text] [Related]
16. Science Signaling Podcast for 21 June 2016: Nanoparticles to treat type 1 diabetes.
Quintana FJ; VanHook AM
Sci Signal; 2016 Jun; 9(433):c15. PubMed ID: 27330187
[TBL] [Abstract][Full Text] [Related]
17. Multiple mechanisms involved in diabetes protection by lipopolysaccharide in non-obese diabetic mice.
Wang J; Cao H; Wang H; Yin G; Du J; Xia F; Lu J; Xiang M
Toxicol Appl Pharmacol; 2015 Jun; 285(3):149-58. PubMed ID: 25896969
[TBL] [Abstract][Full Text] [Related]
18. Use of a cocktail regimen consisting of soluble galectin-1, rapamycin and histone deacetylase inhibitor may effectively prevent type 1 diabetes.
Jiang GX; Cui YF; Zhong XY; Tai S; Liu W; Wang ZD; Shi YG
Arch Med Res; 2009 Jul; 40(5):424-6. PubMed ID: 19766909
[TBL] [Abstract][Full Text] [Related]
19. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice.
Xia CQ; Peng R; Qiu Y; Annamalai M; Gordon D; Clare-Salzler MJ
Diabetes; 2007 Aug; 56(8):2116-23. PubMed ID: 17496235
[TBL] [Abstract][Full Text] [Related]
20. Looking beyond the induction of Th2 responses to explain immunomodulation by helminths.
Nutman TB
Parasite Immunol; 2015 Jun; 37(6):304-13. PubMed ID: 25869527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
